Removing barriers to insulin therapy

Diabetes Educator

Volumn 33, Issue SUPPL. 3, 2007, Pages

  Peragallo Dittko, Virginia ^a,b  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b NOVO NORDISK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ARTICLE; ATTITUDE TO HEALTH; HUMAN; HYPOGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PAIN; PSYCHOLOGICAL ASPECT; SUBCUTANEOUS DRUG ADMINISTRATION; WEIGHT GAIN;

ATTITUDE TO HEALTH; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; PAIN; WEIGHT GAIN;

EID: 34147215337     PISSN: 01457217     EISSN: 15546063     Source Type: Journal    
DOI: 10.1177/0145721707301210     Document Type: Article

References (14)

1. Alberti G. The DAWN (Diabetes Attitudes, Wishes and Needs) study. Pract Diabetes Int. 2002 ; 19: 22-24.
2. Korytkowski M. When oral agents fail: practical barriers to starting insulin. Int J Obes Relat Metab Disord. 2002 ; 26 (suppl 3). S18 - S24.
3. Peyrot M., Mathews DR, Snoek FJ, et al. An international study of psychological resistance to insulin among persons with diabetes [abstract]. Diabetologia. 2003 ; 46 (suppl 2). A89.
4. Leslie CA, Satin-Rapaport W., Matheson D., et al. Psychological insulin resistance: a missed diagnosis? Diabetes Spectrum. 1994 ; 7: 52-57.
5. Polonsky WH, Fisher L., Guzman S., et al. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care. 2005 ; 28: 2543-2545.
6. Riddle MC The underuse of insulin therapy in North America. Diabetes Metab Res Rev. 2002 ; 18: S42 - S49.
7. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. Intensive diabetes treatment and cardiovascular disease. N Engl J Med. 2005 ; 353: 2643-2653.
8. Peyrot M., Rubin RR, Torsten L., et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study. Diabetes Care. 2005 ; 28: 2673-2679.
9. Funnell MM, Kruger DF, Spencer M. Self-management support for insulin therapy in type 2 diabetes. Diabetes Educ. 2004 ; 30: 274-280.
10. Polonsky WH, Jackson RA What's so tough about taking insulin? Addressing the problem of psychological insulin resistance in type 2 diabetes. Clin Diabetes. 2004 ; 22: 147-150.
11. Polonsky WH, Fisher L., Dowe SK, Edelman SV Why do patients resist insulin therapy? [abstract]. Diabetes. 2003 ; 52: A419.
12. Turner R., Cull C., Holman R. United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med. 1996 ; 124: 136-145.
13. Mundaliar S., Edelman SV Insulin therapy in type 2 diabetes. Endocrinol Metab Clin North Am. 2001 ; 30: 935-982.
14. Freemantle N., Blonde L., Duhot D., et al. Availability of inhaled insulin promotes greater perceived acceptance of insulin therapy in patients with type 2 diabetes. Diabetes Care. 2005 ; 28: 427-428.